Abstract
The last 10 years have seen a dramatic increase in the number of percutaneous transluminal coronary angioplasty (PTCA) procedures performed in the United States. The increase can be attributed to experience and improved technology, which have made PTCA a viable and effective procedure for an increasing number of coronary disease patients--including those with traditional high-risk factors such as advanced age and multivessel disease. Data from 9,000 PTCA procedures performed at the Mid-America Heart Institute of St. Luke's Hospital in Kansas City, Missouri, show high success rates with few complications and low mortality.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
